Close

Publications

FUNK, S; ABBOTT, S; Atkins, BD; Baguelin, M; Baillie, JK; Birrell, P; Blake, J; BOSSE, NI; Burton, J; Carruthers, J; DAVIES, NG; De Angelis, D; Dyson, L; EDMUNDS, WJ; EGGO, RM; Ferguson, NM; Gaythorpe, K; Gorsich, E; Guyver-Fletcher, G; Hellewell, J; Hill, EM; Holmes, A; House, TA; Jewell, C; JIT, M; ... Whittles, LK.
2020
medRxiv preprint - BMJ Yale (2020). 10.1101/2020.11.11.20220962.
Wehler, E; Lautsch, D; Kowal, S; Davies, G; BRIGGS, A; Li, Q; Rajpathak, S; Alsumali, A;
2020
PHARMACOECONOMICS, (2020).39 3 10.1007/s40273-020-00967-7.
Orzechowska, I; Sadique, MZ; Thomas, K; Davis, P; Morris, KP; Mouncey, PR; Peters, MJ; Richards-Belle, A; Tume, LN; Ramnarayan, P; Harrison, DA;
2020
Trials, (2020).21 1 10.1186/s13063-020-04818-w.
FERNANDES, S; Were, V; Gutman, J; Dorsey, G; Kakuru, A; Desai, M; Kariuki, S; Kamya, MR; Ter Kuile, FO; HANSON, K;
2020
The Lancet. Global health, (2020).8 12 10.1016/S2214-109X(20)30369-7.
Pulkki-Brännström, A-M; Haghparast-Bidgoli, H; Batura, N; Colbourn, T; Azad, K; Banda, F; Banda, L; BORGHI, J; Fottrell, E; Kim, S; Makwenda, C; Ojha, AK; Prost, A; Rosato, M; Shaha, SK; Sinha, R; Costello, A; Skordis, J;
2020
Health Policy and Planning, (2020).35 10 10.1093/heapol/czaa081.
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on rifampicin resistant and multidrug resistant tuberculosis in India and China.
WEERASURIYA, C; Harris, R; MCQUAID, C; BOZZANI, F; Gomez, GB; WHITE, R;
2020
(2020).
Estimating the economic burden of post-tuberculosis: data gaps and research priorities.
SWEENEY, S;
2020
(2020).